Rada Miskovic

MD| PhD| clinical immunologist# allergist# lupus # autoimmunity #immunodeficiency. Views are my own!

[Md Yuzaiful Md Yusof @Yuz6Yusof]

🚨Hot of the press in this heatwave. Our #BSR @RheumatologyUK Guideline on the Management of #lupus is out now! 🥳

Our Guideline:

✅Comprehensive
✅Life-course
✅Multidisciplinary
✅Evidence-based
✅Harmonise delivery of care

https://t.co/1egaExblVV

https://t.co/Wof8Ib3iiW

[Rada Miskovic @MiskovicRada]

📍 Risk-adapted therapy may be the next step in LN management.
👉 Triple therapy showed clear benefit in high-risk LN, while lower-risk patients achieved similar outcomes with less intensive regimens #EULAR2026 #LupusNephritis #SLE
👇

[Mrinalini Dey @DrMiniDey]

#OP0223 at #EULAR2026: Not every lupus nephritis patient may need upfront triple therapy. Using EULAR 2025 prognostic factors, triple therapy significantly improved complete renal response only in high-risk patients, supporting more precision-based treatment approach. @RheumNow

[Rada Miskovic @MiskovicRada]

Very grateful to all co-authors and collaborators for this joint work.
@ROLERSproject Banko Ivica Jeremic @DanijelaKaralic Andja Cirkovic

[Rada Miskovic @MiskovicRada]

✨ Very much pleased to share our mini review on the role of EBV in shaping lupus autoimmunity
#lupus #ebv #autoimmunity #immunology #rheumatology
👇 https://t.co/bg2HguvC2h

[Rada Miskovic @MiskovicRada]

👉 New evidence suggest that EBV may play a much more active role in lupus, particularly through transcriptionally distinct EBV-infected B cells capable of driving autoreactive immune responses.
👇

[Md Yuzaiful Md Yusof @Yuz6Yusof]

#EULAR2026 Please find my video summary of a new promising therapy in #SLE - Nipocalimab, an FcRn blockade. Efficacy and safety data from Phase 2 JASMINE-SLE RCT @RheumNow LB0007

https://t.co/7GFRKZGoZR

[Rada Miskovic @MiskovicRada]

🔥 Pre-registrations for the 9th SLEuro Advanced Workshop on SLE are officially OPEN!

✨A unique opportunity for insightful discussions, collaboration, and advancing lupus research and care.

✅ Pre-register: https://t.co/KW30q1ULV8

🌍 Discover more: https://t.co/BEL5CCAemo

[SLEuro @SLEuroSociety]

Pre-registrations for the 9th SLEuro Advanced Workshop on SLE are now OPEN!

📍 Belgrade, Serbia
🗓️ 25-26 September 2026

Pre-register here: https://t.co/RudmXjSxEE
Discover the more: https://t.co/dhP6fYbKfq

[Rada Miskovic @MiskovicRada]

Excited to share that pre-registrations for the 9th SLEuro Advanced Workshop on SLE are now open!
📍 Belgrade, Serbia
🗓️ 25–26 September 2026
Looking forward to welcoming the SLE community to Belgrade this September. 👇👇👇

[SLEuro @SLEuroSociety]

Pre-registrations for the 9th SLEuro Advanced Workshop on SLE are now OPEN!

📍 Belgrade, Serbia
🗓️ 25-26 September 2026

Pre-register here: https://t.co/RudmXjSxEE
Discover the more: https://t.co/dhP6fYbKfq

[Rada Miskovic @MiskovicRada]

We thank all colleagues who contributed to webinars through lectures and discussions.
Also, Serbian Lupus Society participated together with the Serbian Group for Primary Immunodeficiencies in their symposium, contributing to the session dedicated to transition in lupus and IEI.

[Rada Miskovic @MiskovicRada]

🦋 World Lupus Day is a reminder that lupus is a complex and often invisible autoimmune disease that affects many aspects of patients’ lives. There is still a long way to go to improve awareness, early diagnosis, access to treatment, and support for people living with lupus.👇

[Rada Miskovic @MiskovicRada]

So far, four webinars have been organized, focusing on lupus nephritis, treatment of refractory SLE, real-life experience with biologics in lupus, APS and SLE, as well as selected highlights and hot topics from ELM 2026 in Lisbon. 👇

[Rada Miskovic @MiskovicRada]

Progress is happening through education, collaboration and research.
Since January 2026, the Serbian Lupus Society has started a webinar series for its members and interested colleagues, covering different aspects of SLE and related conditions. 👇

[Rada Miskovic @MiskovicRada]

@ivan_padjen Congratulations! A great way to celebrate World Lupus Day!

[Donald Thomas, MD @lupuscyclopedia]

🔥The modern, most accurate method of dosing hydroxychloroquine (HCQ) is by using drug levels and not by body weight for #lupus #SLE #Sjogrens patients.

https://t.co/O5SDXNEeUp

https://t.co/cQINO8nLP0

The best way to dose HCQ is to measure trough, whole blood levels, and aim for 750 – 1150 ng/mL.

Dosing HCQ at 5 mg/kg/d is so old-fashioned. It underdoses many patients, leading to lupus flares, increased disease activity, and hospitalizations. In others, it leads to toxic levels, increasing the risk of side effects like HCQ retinopathy (eye damage).

[Rada Miskovic @MiskovicRada]

Prediction of response to biologics in SLE 👇
Meta-analysis of 31 RCTs showed:
• Serological activity and high disease activity (SLEDAI ≥10) 👉 strongest predictor of response
• Interferon signature 👉 inconsistent signal
#SLE #PrecisionMedicine https://t.co/SEgT1YwDNk

[Casanova Lab @casanova_lab]

From variants to answers: The evolution of genetic counseling in IEI https://t.co/Z6s0iDcjx8

[Dr. John Cush @RheumNow]

Urinary biomarkers improve w/ anifrolumab in TULIP-LN (lupus nephritis) trial; 112 pts, 197 uriniary proteins assessed. Urinary CD163 and MCP-1 signif improved as early as wk 12. Anifrolumab reduced the proteomic inflammatory signature, regardless of responder status https://t.co/vOl5C844VJ

[Rada Miskovic @MiskovicRada]

@lupuscyclopedia Thanks for sharing! 🍀

[Dr. John Cush @RheumNow]

A 2 yr. old female pt reported w/ a a novel P435S gain-of-function variant in TLR7 (thought pathogenic in SLE) - pt dx w/ juvenile SLE, recurrent infection, and neuroinflammatory features. A review of 12 other TLR7 GOF variants revealed similar SLE associations. https://t.co/zNU4dDwift

[Dr. John Cush @RheumNow]

100 women w/ severe preeclampsia (PE) compared to 40 pregnant controls. antiphospholipid antibodies (aPL) was significantly more prevalent iin PE women (34% vs 10%) [OR = 4.63]. aPL positivity was also linked to both early and late severe PE [OR = 4-5, p = .008]. https://t.co/GnRlM691nS